[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100647157":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":31,"responsibleParty":48,"collaborators":20,"id":52,"slug":53,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":56,"acronym":20,"eligibilityCriteria":57,"healthyVolunteers":54,"sex":58,"minAge":59,"maxAge":60,"enrollmentInfo":61,"targetDuration":20,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":70,"overallStatus":33,"whyStopped":20,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Sichuan Provincial People's Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"washed microbiota","EXPERIMENTAL","Study on the effect of washed microbiota transplantation on eradication of refractory Helicobacter pylori infection.",[13],"Biological: transanal fecal bacteria transplant",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"BIOLOGICAL","transanal fecal bacteria transplant","Received transanal fecal bacteria transplant",[9],null,[22,27],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Gao Caiping, Doctor","CONTACT","17708130286","gaocaip@126.com",{"name":28,"role":24,"phone":29,"phoneExt":20,"email":30},"Xia Yuehan, Master","13438917607","694159760@qq.com",[32],{"facility":5,"status":33,"city":34,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"RECRUITING","Chengdu","Sichuan","601172","China","CN",{"type":40,"coordinates":41},"Point",[42,43],104.06667,30.66667,{"lat":43,"lon":42},[46],{"name":47,"role":24,"phone":25,"phoneExt":20,"email":26},"Caiping Gao, Doctor",{"type":49,"investigatorFullName":50,"investigatorTitle":51,"investigatorAffiliation":5,"oldNameTitle":20,"oldOrganization":20},"PRINCIPAL_INVESTIGATOR","Gao Caiping","Chief physician","100647157","phase-4-study-on-the-effect-of-fecal-microbiota-transplantation-on-eradication-of-refractory-helicobacter-pylori-infection-100647157",false,"NCT07704255","Study on the Effect of Fecal Microbiota Transplantation on Eradication of Refractory Helicobacter Pylori Infection","Inclusion Criteria:\n\n* 1\\. Ages 18-70\n* 2\\. Hp infection treatment failed ≥4 times with guidelines-recommended therapies\n* 3\\. Patients with early gastric cancer, peptic ulcer, gastric MALT lymphoma, atrophic gastritis and other diseases requiring the eradication of Hp.\n\nExclusion Criteria:\n\n* 1\\. Antibiotics and bismuth were taken within 4 weeks before this treatment; Or had taken PPI, H2 receptor antagonist, P-CAB within 2 weeks prior to treatment;\n* 2\\. Pregnant or lactating women;\n* 3\\. Those who are allergic to the investigational drugs used in this test or have contraindications;\n* 4\\. Participated in other drug trials within 3 months before the treatment of this trial;\n* 5\\. There are other serious diseases that affect the evaluation of this study at the same time, or they cannot correctly express their own complaints and cannot cooperate;\n* 6\\. Subjects with dysphagia;\n* 7\\. Patients with malignant tumors, serious concomitant diseases, severe ulcer bleeding or perforation;\n* 8\\. Patients judged by the investigator to be unsuitable for clinical trials.\n* 9\\. Those who do not want to sign the informed consent for the study.","ALL","18 Years","80 Years",{"count":62,"type":63},10,"ESTIMATED","INTERVENTIONAL",[66],"PHASE4","To determine whether regulating the gut microbiota can contribute to the eradication of refractory H. pylori infection.",[69],"Helicobacter Pylori Infection",[9],"2026-07-10",{"date":73,"type":74},"2026-07-15","ACTUAL",{"date":76,"type":63},"2026-07-20",{"date":78,"type":63},"2026-12-31",{"name":5,"class":6},1]